• Profile
Close

IMP3 as a prognostic biomarker in patients with malignant peritoneal mesothelioma

Human Pathology Jul 24, 2018

Hui S, et al. - Researchers assessed the prognostic significance of IMP3 and Fli-1 in malignant peritoneal mesothelioma (MPeM). For this investigation, diagnostic biopsies of 44 MPeM subjects were centrally gathered and were immunohistochemically examined for expression of IMP3, Fli-1, and Ki-67. They found that tumor-directed treatment, a lower PCI, Stage I, lower Ki-67LI and lower level IMP3 expression had a statistically significant positive effect on overall survival. The main finding of this study was that IMP3, along with tumor-directed treatment protocols, was a powerful prognosticator in patients with MPeM.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay